医薬経済は医療・医薬を取り巻く環境の“いま”にフォーカス!

MENU

RISFAX June 29, 2017

日本語

Drug Vial Optimization (DVO)” is “essential”
LDP’s administrative reform headquarters vice chairman Suzuki, gathering of patients is also expected in future

MHLW to consider “more reward” if manufacturing cost is clear
Under the cost calculation method, both sides opposed to “reward is insufficient” at present